SCHEMBL19737073

SCHEMBL19737073

CCc1cncc(-c2cc(O)n[nH]2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 2/20 0.40
WDR77 Q9BQA1 2/20 0.40
IDO1 P14902 1/20 0.36
FGFR1 P11362 1/20 0.35
TNIK Q9UKE5 2/20 0.34
CYP11B2 P19099 2/20 0.34
NOTUM Q6P988 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
GFER P55789 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
GPR55 Q9Y2T6 2/20 0.32
FDPS P14324 1/20 0.32
CYP2A6 P11509 1/20 0.32
CLK2 P49760 1/20 0.32
CLK3 P49761 1/20 0.32
DYRK1A Q13627 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17858734 0.78 TNIK (0.39) PRMT5WDR77TNIKCYP11B2NPC1
SCHEMBL19199562 0.76 RAB9A (0.58) PRMT5WDR77IDO1CYP11B2NPC1
SCHEMBL19736896 0.74 KMT2A (0.41) TNIKCYP11B2NPC1RAB9AALDH1A1
SCHEMBL13177775 0.70 CYP1A1 (0.45) PRMT5WDR77IDO1CYP11B2GPR55
SCHEMBL10271979 0.68 CYP11B1 (0.54) PRMT5WDR77IDO1CYP11B2CYP3A4
SCHEMBL12525157 0.67 PRMT5 (0.41) PRMT5WDR77CYP11B2GPR55FDPS
SCHEMBL240843 0.67 SMYD3 (0.39) PRMT5WDR77MAPTALDH1A1
SCHEMBL10263371 0.67
SCHEMBL13886508 0.66 SMN1; SMN2 (0.40) TNIKNOTUMNPC1MAPTRAB9A
SCHEMBL7998222 0.66 PDPK1 (0.47) TNIKNOTUMMAPTRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170360788-A1 SMALL MOLECULE INHIBITORS OF EGFR AND PI3K THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170360788-A1 SMALL MOLECULE INHIBITORS OF EGFR AND PI3K EGFR, ERBB2, ERBB3 PRMT5 1045/4885WDR77 4437/4885IDO1 2156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.